EE113 Comparing Partitioned Survival and State Transition Modeling Approaches: A Case Study of Osimertinib Versus Pemetrexed-Platinum
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.364
https://www.valueinhealthjournal.com/article/S1098-3015(22)00565-4/fulltext
Section Title :
Section Order :
10318
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00565-4&doi=10.1016/j.jval.2022.04.364